|1.||Pathologic Constriction (Stenosis)
|2.||Vascular System Injuries
|1.||Weber, Christian: 24 articles (06/2014 - 09/2002)|
|2.||Serruys, Patrick W: 17 articles (11/2015 - 12/2003)|
|3.||Jang, Yangsoo: 17 articles (02/2015 - 05/2006)|
|4.||Nagai, Ryozo: 16 articles (02/2014 - 01/2002)|
|5.||Virmani, Renu: 16 articles (11/2013 - 02/2002)|
|6.||Zhang, Chunxiang: 15 articles (02/2013 - 03/2004)|
|7.||Sata, Masataka: 14 articles (12/2015 - 01/2002)|
|8.||Otake, Hiromasa: 14 articles (08/2015 - 04/2007)|
|9.||Zernecke, Alma: 14 articles (02/2014 - 02/2006)|
|10.||Shinke, Toshiro: 13 articles (08/2015 - 04/2007)|
|1.||glucuronyl glucosamine glycan sulfate (Vessel)IBA
06/01/2003 - "Angiographic lumen diameter was significantly greater at 28 days in high flow than low flow normal diet animals, attributable on perfusion-fixed vessel morphometry to altered remodeling (area within the external elastic lamina: high flow 1.85+/-0.24 vs. low flow 1.31+/-0.04 mm(2), P<0.05) rather than differences in neointima formation or vessel tone. "
03/01/2015 - "This study demonstrates that after an Absorb BVS implantation neointima tissue develops that covers almost the whole circumference of the vessel wall. "
06/01/2006 - "The purpose of this present study was to culture SMC from normal vessel wall and from neointima and to compare migration and growth of these cells. "
04/01/2001 - "Prior studies have shown that intracoronary radiation (IR) prevents neointima accumulation, but its contribution to vessel remodeling is unknown. "
04/01/1996 - "Whole vessel wall organ culture systems have been developed to study the early stages of neointima formation. "
|2.||Phenobarbital (Luminal)FDA Link
05/01/2014 - "In our previous studies, however, TGF-β1 expression in coronary arteries actually reduced neointima formation without affecting luminal loss postangioplasty, while expression of a TGF-β1 antagonist (RIIs) in balloon-injured coronary arteries reduced luminal loss without affecting neointima formation. "
07/01/2010 - "Cytochemistry studies localized apelin expression to luminal endothelial cells and apelin receptor upregulation to smooth muscle cells (SMC) in the media and neointima. "
06/01/2009 - "This angiographic and angioscopic study suggests that white neointima of the BMS may often change into yellow plaque over an extended period of time, and atherosclerotic progression inside the BMS may contribute to late luminal narrowing."
03/28/2000 - "The current study used a direct approach to test the hypothesis that, after balloon injury of the rat carotid artery, adventitial fibroblasts migrate in a luminal direction and contribute to neointima formation. "
11/22/2015 - "In Absorb BVS, neointima tissue continued to develop at midterm follow-up (2.17±0.48 mm2 vs. 1.38±0.52 mm2, p<0.0001) and covered the underlying tissues without compromising the luminal dimensions (5.93±1.49 mm2 vs. 6.14±1.49 mm2, p=0.571) as it was accommodated by the expanded scaffold (8.28±1.74 mm2 vs. 7.67±1.28 mm2, p<0.0001). "
|3.||Apolipoproteins E (ApoE)IBA
10/01/2015 - "Additionally, we utilised a model of neointima formation based on the placement of a perivascular collar around the carotid artery in ApoE(-/-) mice to ascertain whether B cells and B cell subsets confer protection against lesion development. "
11/01/2007 - "Altogether, the results of the present study indicate that although lesion composition may be influenced by genotype, neointima formation and arterial remodeling in the murine perivascular carotid collar model occur independent of the exposure to atherogenic diet or the presence of a sensitized genotype such as apoE-/-. "
01/01/2015 - "Both in wire-injured femoral arteries in MRTF-A knockout (Mkl1-/-) mice and atherosclerotic lesions in Mkl1-/-; ApoE-/- mice, neointima formation were significantly attenuated and the expression of AQP1 were significantly decreased. "
01/01/2015 - "MRTF-A, AQP1 and neointima expression was detected both in the wire injured femoral arteries of wild-type mice and the atherosclerotic aortic tissues of ApoE-/- mice. "
10/07/2014 - "Furthermore, asTF gene transfer significantly increased neointima formation and neovascularization after carotid wire injury in ApoE(-/-) mice. "
|4.||Sirolimus (Rapamycin)FDA Link
02/01/2012 - "Therefore, the inhibition of CXCR4 by POL5551 is equally effective in preventing neointima formation as sirolimus, but POL5551 might be more beneficial because treatment with it results in a more stable lesion phenotype and because it does not impair re-endothelialisation."
04/01/2004 - "In this study, we investigated the expression of mTOR in human neointima and the effect of rapamycin on global transcriptional events controlling CASMC phenotype. "
10/10/2014 - "Our data collectively show that a rapamycin-loaded PCL delivery system produces substantial mitigation of neointima, likely due to its favorable physical properties leading to a stable yet flexible perivascular sheath and steady and prolonged release kinetics. "
02/01/2012 - "The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation."
06/01/2005 - "Short-term rapamycin for inhibition of neointima formation after balloon-mediated aortic injury in rats: is there a window of opportunity for systemic prophylaxis of restenosis?"
|5.||Paclitaxel (Taxol)FDA LinkGeneric
11/29/2011 - "In efficacy studies using a rat carotid injury model, paclitaxel (0.3 mg/kg or 1 mg/kg) was i.v. administered postprocedure on days 0 and 5. The targeted NP group resulted in lower neointima-to-media (N/M) scores at 2 wk versus control groups of saline, paclitaxel, or nontargeted NPs. "
07/15/1997 - "The present study was designed to characterize the effects of paclitaxel on proliferation and migration of human arterial smooth muscle cells (haSMCs) in vitro and on neointima formation in an in vivo experimental rabbit model. "
02/01/2008 - "These results support the notion that slowing the release rate and lowering the dose of paclitaxel favorably influences the vascular biological response to DES implant, decreasing early toxicity and promoting stable healing while still suppressing neointima formation."
10/01/2006 - "Local adventitial delivery of paclitaxel significantly attenuated neointima formation. "
11/01/2013 - "In contrast to paclitaxel-eluting stents, reduced neointima formation in GCH-Tg mice was accompanied by increased endothelial cell coverage (156 ± 17 vs. 209 ± 23 nuclei/mm(2), P = 0.043). "
01/27/2004 - "Conversely, the content of SMCs and of collagen in the neointima were increased, amounting to a slight but not significant reduction in neointima and media size after 3 weeks of MIF monoclonal antibody treatment. "
01/01/2015 - "Of 81 cross-sections, histological analysis revealed that the homogeneous pattern of neointima on OCT (n=39) contained smooth muscle cells with collagen, indicating high neointimal maturity. "
06/01/2013 - "SHG-based collagen imaging of the outer arterial wall facilitated analysis of the macrophage-rich, inflamed neointima. "
05/01/2013 - "The neointima comprised predominantly smooth muscle cells and collagen fibers. "
08/01/2012 - "The neointima was composed predominantly of smooth muscle cells and collagen fibers. "
|7.||Polytetrafluoroethylene (Teflon)FDA Link
01/06/2009 - "To study the morphological behavior, the expression of MCP-1 and PDGF-B of distal anastomotic neointima after expanded polytetrafluoroethylene (ePTFE) bypass grafting. "
01/01/1989 - "However, results of this study suggested that Plasma-TFE treatment had no effect on tissue penetration and neointima formation after implantation into the abdominal aorta of the dog for 8 weeks."
05/01/2004 - "Histopathology demonstrated the presence of neointima in both SIS and PTFE. "
07/01/2002 - "Differences in neointima formation between impervious and porous polytetrafluoroethylene vascular patch material."
12/01/1985 - "The neointima in externally stented polytetrafluoroethylene conduits was thin and uniform and did not extend onto the leaflets or limit their mobility. "
|8.||Proliferating Cell Nuclear Antigen (PCNA)IBA
01/01/2012 - "Our in vivo studies using a mouse carotid arterial injury model revealed that treatment with 150 mg/kg DIM resulted in significant reduction of the neointima/media ratio and proliferating cell nuclear antigen (PCNA)-positive cells, without affecting apoptosis of vascular cells and reendothelialization. "
09/01/1995 - "In this study we quantified the time course of neointima formation by morphometry, and smooth muscle cell (SMC) proliferation by immunocytochemistry for proliferating cell nuclear antigen (PCNA), in the pig carotid artery 0-28 days following balloon injury. "
01/01/2016 - "Neointima formation was exaggerated in LPO compared with NPO and associated with an increase in cell proliferation assessed by proliferating cell nuclear antigen (PCNA) staining index. "
09/01/2015 - "In a rat balloon injury model, mir-542-3p inhibited neointima formation and proliferating cell nuclear antigen (PCNA) protein expression. "
10/01/2014 - "These findings demonstrated that IRF7 modulated VSMC proliferation and neointima formation by interacting with ATF3, thereby inhibiting the ATF3-mediated induction of PCNA transcription. "
10/01/2004 - "Previously, we showed that Axl expression correlated with neointima formation in balloon-injured rat carotid, and that Axl expression was highly regulated by angiotensin II. In the present study we tested the mechanisms by which Axl regulates vascular smooth muscle cell (VSMC) growth focusing on its ability to inhibit apoptosis. "
06/01/2011 - "Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice."
01/01/2010 - "Bone marrow (BM)-derived endothelial progenitor cells (EPCs) and vascular smooth muscle progenitor cells (VPCs) contribute to neointima formation, whereas the angiotensin II (Ang II) type 1 receptor (AT(1))-mediated action on BM-derived progenitors remains undefined. "
09/01/1996 - "Smooth muscle DNA replication in response to angiotensin II is regulated differently in the neointima and media at different times after balloon injury in the rat carotid artery. "
09/30/1992 - "These results prove that angiotensin II plays a key role as a mediator of vascular neointima formation."
01/16/2008 - "In two different in vivo PIRS models we found that SREBP-1 was enhanced in the injured blood vessel wall, especially within the neointima and co-localized with alpha-smooth muscle actin positive cells. "
07/01/2006 - "In contrast, preoperative followed by intraoperative CO administration increased COHgb in a sustained fashion and inhibited neointima formation by 51.7% and I/M by 31% (P < .001). "
10/03/2005 - "Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries."
03/01/2004 - "Moreover, co-immunoprecipitation experiments revealed the presence of a STAT5/Tie2 molecular complex in neointima vessels from advanced, but not from early, lesions. "
01/01/2014 - "Bone marrow cells did not contribute to neointima SMCs in vein grafts, but did co-stain with markers of inflammatory cells. "
04/01/2001 - "Although external stenting is highly effective in reducing neointima formation after vein grafting, the properties of the stent material necessary for this effect have not been defined. "
01/01/2010 - "Local eNOS production suppressed smooth muscle cell proliferation and promoted re-endothelialization of the artery showing a significant reduction in restenosis of 1.75 neointima/media ratio for stents with lipoplexes encoding eNOS compared with 2.3 neointima/media ratio for stents with lipoplexes encosing an empty vector. "
07/01/2008 - "At 9 months' follow-up, the incidence of inadequately apposed stent (33% vs. 4%, p = 0.012) and partially uncovered stent by neointima (72% vs. 37%, p = 0.019) was significantly greater in UAP patients than that in SAP patients. "
12/01/2011 - "This study shows favourable vascular compatibility and efficacy for a novel DES to inhibit in-stent neointima formation and preserve lumen area in the porcine artery model."
06/01/2013 - "The aim of our study was to develop a CD133-cell-capturing bare-metal stent and investigate feasibility, safety, and efficacy of CD133-stents in terms of re-endothelialization and neointima inhibition. "
07/01/2006 - "The thickness and area of the neointima were significantly greater in the control grafts than in the grafts with perivenous support (P<0.05), and the proliferation of vascular smooth muscle cells in the supported graft was less active (P<0.05). "
02/01/1998 - "Reduced medial thickening, neointima formation, and cell proliferation were sustained in externally stented grafts, and these effects were associated with a significant reduction in PDGF expression."
10/01/2002 - "These results demonstrated the efficacy of intraoperative transfection of the NFkappaB decoy into the vein graft wall for attenuation of neointima formation."
01/20/2012 - "To study how FSP-1 contributes to neointima formation of vein grafts. "
08/03/2010 - "To study the expression of cell cycle related factor Gli2 in autogenous vein graft and its relation with neointima formation. "
05/01/2010 - "sEH knockout or inhibition resulted in a significant reduction of neointima formation in the femoral artery cuff model but not following carotid artery ligation. "
01/01/2006 - "Early recombinant TM treatment in mice undergoing carotid ligation altered vascular remodeling and decreased the severity of neointima formation."
01/01/2014 - "In the current study we examined the contribution of the previously differentiated vascular smooth muscle cells to the neointima that forms following carotid artery ligation. "
01/01/2006 - "In the study, we investigated the role of TM in vascular remodeling and neointima formation in a mouse carotid ligation model. "
10/01/2015 - "Crem(-/-) mice exhibited an increased neointima formation after carotid ligation associated with an increased proliferation of VSMCs in the carotid media. "
|4.||Angioplasty (Angioplasty, Transluminal)
01/01/1994 - "In conclusion, single topical application of AT1 receptor antagonists was effective in suppressing early medial proliferation and neointima formation after balloon injury, suggesting that they may be clinically useful after angioplasty or vascular surgery."
04/01/2005 - "This study reveals the importance of FKHRL1 in proliferation and viability of VSMCs and suggests that it may serve as a molecular target for interventions to reduce neointima formation after angioplasty."
12/01/2014 - "Neointima formation following angioplasty is a serious consequence of endothelial damage in arteries. "
02/01/2012 - "In arterial VSMC, expression of the cell cycle inhibitor, p27, rapidly decreases after angioplasty, and replacement of p27 markedly reduces neointima development. "
05/01/2009 - "For each time point, one animal was euthanized 24 h after injection to identify the location of the proliferating cells, while a second animal was euthanized 25 days after angioplasty to determine whether the proliferating cells migrated to form the neointima. "
08/14/1996 - "Intracoronary radiation therapy was shown to be effective in limiting "restenosis-like" phenomena by inhibiting neointima formation after balloon angioplasty in porcine coronary arteries. "
10/02/2001 - "Previous studies suggest that the migration of adventitial cells into the neointima after balloon angioplasty might have an important role in vascular lesion formation. "
12/01/2014 - "To clarify the therapeutic effect at the site of neointima, balloon angioplasty of the rabbit carotid arteries was performed at 4 weeks after initial endothelial denudation. "
02/15/2014 - "AGE-aptamer might be a novel therapeutic strategy for suppressing neointima formation after balloon angioplasty."
10/01/2012 - "Therefore, we investigated the condition of the neointima after ELCA for ISR with optical coherence tomography (OCT) and compared the OCT findings and clinical outcome between ELCA and cutting-balloon angioplasty (CBA). "